Sustained virological response with 16‐week glecaprevir/pibrentasvir after failure to sofosbuvir/velpatasvir in post‐transplant severe HCV recurrence in HIV-Reference-Cited by-同舟云学术

Sustained virological response with 16‐week glecaprevir/pibrentasvir after failure to sofosbuvir/velpatasvir in post‐transplant severe HCV recurrence in HIV

Published:2019-09-15 Issue:6 Volume:21 Page:
ISSN:1398-2273
Container-title:Transplant Infectious Disease
language:en
Short-container-title:Transpl Infect Dis

Author:

Merli Marco¹^ORCID,Rossotti Roberto¹,Travi Giovanna¹,Ferla Fabio²,Lauterio Andrea²,Angelini Zucchetti Teresa³,Alcantarini Chiara⁴,Bargiacchi Olivia⁵,De Carlis Luciano²⁶,Puoti Massimo¹

Affiliation:

1. Division of Infectious Diseases ASST Grande Ospedale Metropolitano Niguarda Milano Italy

2. Division of General Surgery & Abdominal Transplantation ASST Grande Ospedale Metropolitano Niguarda Milano Italy

3. Division of Pharmacy ASST Grande Ospedale Metropolitano Niguarda Milano Italy

4. Department of Medical Sciences Unit of Infectious Diseases Amedeo di Savoia Hospital University of Torino Torino Italy

5. Infectious Diseases Section “Maggiore della Carità” Hospital Novara Italy

6. School of Medicine University of Milano‐Bicocca Milano Italy

Publisher

Wiley

Subject

Infectious Diseases,Transplantation

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/tid.13165

Reference13 articles.

1. Outcomes of liver transplant recipients with hepatitis C and human immunodeficiency virus coinfection

2. Outcome of HCV/HIV-Coinfected Liver Transplant Recipients: A Prospective and Multicenter Cohort Study

3. Sofosbuvir-Based Regimens in HIV/HCV Coinfected Patients After Liver Transplantation

4. Direct-acting antivirals are effective and safe in HCV/HIV-coinfected liver transplant recipients who experience recurrence of hepatitis C: A prospective nationwide cohort study

5. International Liver Transplantation Society Consensus Statement on Hepatitis C Management in Liver Transplant Recipients

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fibrosing cholestatic hepatitis as a variant of the course of hepatotropic viruses’ infection;Epidemiology and Infectious Diseases;2024-06-10

2. Virological Factors Associated with Failure to the Latest Generation of Direct Acting Agents (DAA) and Re-Treatment Strategy: A Narrative Review;Viruses;2021-03-08

3. Japanese Man with HCV Genotype 4 Infection and Cirrhosis Who was Successfully Treated by the Combination of Glecaprevir and Pibrentasvir;Internal Medicine;2021

4. Seronegative fibrosing cholestatic hepatitis С after liver retransplantation for unresectable neuroendocrine tumor liver metastases;Transplantologiya. The Russian Journal of Transplantation;2020-12-11

5. Basiliximab/methylprednisolone/tacrolimus;Reactions Weekly;2020-02